I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Elotuzumab, pomalidomide, and dexamethasone is a very well ..:
Hose, Dorothea
;
Schreder, Martin
;
Hefner, Jochen
...
Journal of Cancer Research and Clinical Oncology. 147 (2020) 1 - p. 205-212 , 2020
Link:
https://doi.org/10.1007/s00432-020-03323-6
RT Journal T1 <Title>Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s00432-020-03323-6&Exemplar=1&LAN=DE A1 Hose, Dorothea A1 Schreder, Martin A1 Hefner, Jochen A1 Bittrich, Max A1 Danhof, Sophia A1 Strifler, Susanne A1 Krauth, Maria-Theresa A1 Schoder, Renate A1 Gisslinger, Bettina A1 Einsele, Hermann A1 Gisslinger, Heinz A1 Knop, Stefan PB Springer Science and Business Media LLC YR 2020 SN 0171-5216 SN 1432-1335 JF Journal of Cancer Research and Clinical Oncology VO 147 IS 1 SP 205 OP 212 LK http://dx.doi.org/https://doi.org/10.1007/s00432-020-03323-6 DO https://doi.org/10.1007/s00432-020-03323-6 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
